X-104252793-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000372588.4(ESX1):āc.542A>Gā(p.Asp181Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,209,168 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000372588.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESX1 | NM_153448.4 | c.542A>G | p.Asp181Gly | missense_variant | 3/4 | ENST00000372588.4 | NP_703149.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESX1 | ENST00000372588.4 | c.542A>G | p.Asp181Gly | missense_variant | 3/4 | 1 | NM_153448.4 | ENSP00000361669 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000891 AC: 1AN: 112292Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34452
GnomAD3 exomes AF: 0.0000383 AC: 7AN: 182530Hom.: 0 AF XY: 0.0000746 AC XY: 5AN XY: 66980
GnomAD4 exome AF: 0.0000292 AC: 32AN: 1096876Hom.: 0 Cov.: 28 AF XY: 0.0000359 AC XY: 13AN XY: 362270
GnomAD4 genome AF: 0.00000891 AC: 1AN: 112292Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.542A>G (p.D181G) alteration is located in exon 3 (coding exon 3) of the ESX1 gene. This alteration results from a A to G substitution at nucleotide position 542, causing the aspartic acid (D) at amino acid position 181 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at